Just because a person is dying does not mean that he or she is in a state of panic. Here’s an example of how one woman, through a well-lived life, remained at peace as she faced death.
Articles on Cancer care
Displaying 21 - 23 of 23 articles
NSW is about to embark on the largest and most definitive clinical trial ever of medicinal cannabis for chemotherapy-induced nausea and vomiting.
Most of us would agree that cancer drugs should be listed on the PBS, no matter how dear. But our health system can’t afford all of them. How then are decisions about which drugs to subsidise made?
Top contributors
-
Ottawa Health Services Network Inc.
-
Associate professor, Department of Health Sciences, Carleton University
-
Professor, Deakin University
-
David A. Cofrin Professor of Urologic Oncology and Chair of the Department of Urology, University of Florida
-
Associate Professor in Health Economics, Flinders University
-
Associate professor, University of Sydney
-
Chancellor's Professor of Medicine, Liberal Arts, and Philanthropy, Indiana University
-
Professor of Health Economics, Flinders University
-
Principal Communications and Events Officer Centre for Medicinal Cannabis Research and Innovation Office of the NSW Chief Scientist & Engineer, Office of the Chief Scientist
-
Medical oncologist from Chris O`Brien Lifehouse cancer hospital, Lead researcher NSW Government clinical trial into the role of cannabis-derived medicines in chemotherapy-induced nausea and vomiting, Clinical Associate Professor., University of Sydney
-
Research Fellow, Flinders University
-
Matthew Flinders Professor in Exercise & Cancer, Flinders University; Peter MacCallum Cancer Centre
-
Honorary Professor, Faculty of Medicine, University of British Columbia, University of British Columbia
-
Professor of Medicine, University of Florida
-
Research Fellow, Equitable Cancer Outcomes across Rural and Remote Australia (ECORRA), Deakin University